Horizon Illumination Lab Optics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 9

Horizon Illumination Lab Optics General Information

Description

Developer of an optical diagnostic agent designed for the treatment of chronic myeloid leukemia. The company's agent visualizes the effects of molecularly targeted drugs on each living cell to measure the efficacy by introducing cancer cells to the drug agents, enabling doctors to measure the effects of other cancer therapeutics by partially changing their structure and providing optimal treatment for each patient.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2-12 Kita 21-jo Nishi
  • Kita-ku
  • Sapporo, Hokkaido 001-0021
  • Japan
+81
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 2-12 Kita 21-jo Nishi
  • Kita-ku
  • Sapporo, Hokkaido 001-0021
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Horizon Illumination Lab Optics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 29-Nov-2024 Completed Clinical Trials - General
4. Accelerator/Incubator Completed Clinical Trials - General
3. Seed Round 01-Feb-2023 Completed Clinical Trials - General
2. Accelerator/Incubator 01-Nov-2022 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Horizon Illumination Lab Optics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Horizon Illumination Lab Optics Patents

Horizon Illumination Lab Optics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4589011-A1 Reagent for measuring tyrosine kinase activity, and use thereof Pending 12-Sep-2022
US-20260092919-A1 Reagent for measuring tyrosine kinase activity, and use thereof Pending 12-Sep-2022
WO-2024058178-A1 Reagent for measuring tyrosine kinase activity, and use thereof Inactive 12-Sep-2022 C07K14/71

Horizon Illumination Lab Optics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Horizon Illumination Lab Optics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
D2 Garage Venture Capital Minority
Green Core Venture Capital Minority
Japan Science And Technology Agency Government Minority
DG Ventures Corporate Venture Capital Minority
Hokkaido 21st Century Research Institute Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Horizon Illumination Lab Optics FAQs

  • When was Horizon Illumination Lab Optics founded?

    Horizon Illumination Lab Optics was founded in 2021.

  • Where is Horizon Illumination Lab Optics headquartered?

    Horizon Illumination Lab Optics is headquartered in Sapporo, Japan.

  • What is the size of Horizon Illumination Lab Optics?

    Horizon Illumination Lab Optics has 10 total employees.

  • What industry is Horizon Illumination Lab Optics in?

    Horizon Illumination Lab Optics’s primary industry is Drug Discovery.

  • Is Horizon Illumination Lab Optics a private or public company?

    Horizon Illumination Lab Optics is a Private company.

  • What is Horizon Illumination Lab Optics’s current revenue?

    The current revenue for Horizon Illumination Lab Optics is .

  • Who are Horizon Illumination Lab Optics’s investors?

    D2 Garage, Green Core, Japan Science And Technology Agency, DG Ventures, and Hokkaido 21st Century Research Institute are 5 of 9 investors who have invested in Horizon Illumination Lab Optics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process